Login
Home
Charts
Search
Watchlist
Products

Kanoria Chemicals & Industries Ltd

KANORICHEM·NSE
173.57-3.59%Tue, 22 Sept '26 15:31

Kanoria Chemicals & Industries Ltd

KANORICHEM
NSE
173.57
-3.59%
|Tue, 22 Sept '26 15:31
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
757Cr
Close
Close Price
173.15
Industry
Industry
Chemicals - Organic - Alcohol Based
PE
Price To Earnings
4.88
PS
Price To Sales
0.61
Revenue
Revenue
1,240Cr
Rev Gr TTM
Revenue Growth TTM
25.33%
PAT Gr TTM
PAT Growth TTM
254.89%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
371342361384177180431201210266304460
Growth YoY
Revenue Growth YoY%
2.6-11.3-18.8-4.2-52.5-47.219.4-47.618.847.4-29.4128.6
Expenses
ExpensesCr
365339333382176165414183204246277415
Operating Profit
Operating ProfitCr
6329201517186202745
OPM
OPM%
1.60.87.90.50.18.43.99.03.07.58.99.8
Other Income
Other IncomeCr
0811121-27112277
Interest Expense
Interest ExpenseCr
1291211881279887
Depreciation
DepreciationCr
15151515881699999
PBT
PBTCr
-21-132-23-40-383161735
Tax
TaxCr
-12181722332-159
PAT
PATCr
-21-15-16-23-16-29-40-149243226
Growth YoY
PAT Growth YoY%
-23.7-283.6-1,643.3-497.119.7-88.0-155.639.9657.1112.4178.8291.3
NPM
NPM%
-5.5-4.5-4.3-6.0-9.3-15.9-9.3-6.843.81.310.45.7
EPS
EPS
-4.2-1.9-2.1-3.8-3.2-3.8-8.3-1.821.40.87.26.0
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
371342361384177180431201210266304460
Growth YoY
Revenue Growth YoY%
2.6-11.3-18.8-4.2-52.5-47.219.4-47.618.847.4-29.4128.6
Expenses
ExpensesCr
365339333382176165414183204246277415
Operating Profit
Operating ProfitCr
6329201517186202745
OPM
OPM%
1.60.87.90.50.18.43.99.03.07.58.99.8
Other Income
Other IncomeCr
0811121-27112277
Interest Expense
Interest ExpenseCr
1291211881279887
Depreciation
DepreciationCr
15151515881699999
PBT
PBTCr
-21-132-23-40-383161735
Tax
TaxCr
-12181722332-159
PAT
PATCr
-21-15-16-23-16-29-40-149243226
Growth YoY
PAT Growth YoY%
-23.7-283.6-1,643.3-497.119.7-88.0-155.639.9657.1112.4178.8291.3
NPM
NPM%
-5.5-4.5-4.3-6.0-9.3-15.9-9.3-6.843.81.310.45.7
EPS
EPS
-4.2-1.9-2.1-3.8-3.2-3.8-8.3-1.821.40.87.26.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5657028371,0721,0051,0951,3691,5781,4751,5379811,240
Growth
Revenue Growth%
6.424.219.228.1-6.39.025.115.3-6.54.2-36.125.3
Expenses
ExpensesCr
5356758021,0089771,0011,3011,5061,4231,5059101,142
Operating Profit
Operating ProfitCr
302735642894687252317198
OPM
OPM%
5.33.84.15.92.88.65.04.63.52.07.37.9
Other Income
Other IncomeCr
177457228291019-202229
Interest Expense
Interest ExpenseCr
142024363732273643463232
Depreciation
DepreciationCr
344547495658575959633536
PBT
PBTCr
-1-3210-15-431113-12-31-972759
Tax
TaxCr
6-8-25-11-51112112-60
PAT
PATCr
-7-2412-20-32162-13-52-10932153
Growth
PAT Growth%
-158.4-229.4148.8-268.5-61.8150.7-86.0-676.9-301.4-110.9129.7254.9
NPM
NPM%
-1.3-3.41.4-1.8-3.11.50.2-0.8-3.5-7.13.312.4
EPS
EPS
-1.6-5.43.2-3.4-5.93.31.6-2.0-8.8-19.127.635.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5657028371,0721,0051,0951,3691,5781,4751,5379811,240
Growth
Revenue Growth%
6.424.219.228.1-6.39.025.115.3-6.54.2-36.125.3
Expenses
ExpensesCr
5356758021,0089771,0011,3011,5061,4231,5059101,142
Operating Profit
Operating ProfitCr
302735642894687252317198
OPM
OPM%
5.33.84.15.92.88.65.04.63.52.07.37.9
Other Income
Other IncomeCr
177457228291019-202229
Interest Expense
Interest ExpenseCr
142024363732273643463232
Depreciation
DepreciationCr
344547495658575959633536
PBT
PBTCr
-1-3210-15-431113-12-31-972759
Tax
TaxCr
6-8-25-11-51112112-60
PAT
PATCr
-7-2412-20-32162-13-52-10932153
Growth
PAT Growth%
-158.4-229.4148.8-268.5-61.8150.7-86.0-676.9-301.4-110.9129.7254.9
NPM
NPM%
-1.3-3.41.4-1.8-3.11.50.2-0.8-3.5-7.13.312.4
EPS
EPS
-1.6-5.43.2-3.4-5.93.31.6-2.0-8.8-19.127.635.5

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
2222222222222222222222
Reserves
ReservesCr
581558566577547565577584579499551
Current Liabilities
Current LiabilitiesCr
259291365412404375409509509571309
Non Current Liabilities
Non Current LiabilitiesCr
344330319374389391392366364416235
Total Liabilities
Total LiabilitiesCr
1,2251,2091,2781,4011,3741,3621,4031,4811,4901,4981,117
Current Assets
Current AssetsCr
331338395456434459506572563567286
Non Current Assets
Non Current AssetsCr
893872883945940903897909928932831
Total Assets
Total AssetsCr
1,2251,2091,2781,4011,3741,3621,4031,4811,4901,4981,117
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
2222222222222222222222
Reserves
ReservesCr
581558566577547565577584579499551
Current Liabilities
Current LiabilitiesCr
259291365412404375409509509571309
Non Current Liabilities
Non Current LiabilitiesCr
344330319374389391392366364416235
Total Liabilities
Total LiabilitiesCr
1,2251,2091,2781,4011,3741,3621,4031,4811,4901,4981,117
Current Assets
Current AssetsCr
331338395456434459506572563567286
Non Current Assets
Non Current AssetsCr
893872883945940903897909928932831
Total Assets
Total AssetsCr
1,2251,2091,2781,4011,3741,3621,4031,4811,4901,4981,117

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1230272231828326381366
Investing Cash Flow
Investing Cash FlowCr
-1097-21-86-3-12-43-29-50-59-37
Financing Cash Flow
Financing Cash FlowCr
82-39-1173-11-75-533543-25
Net Cash Flow
Net Cash FlowCr
-15-2-5917-4-130-8-35
Free Cash Flow
Free Cash FlowCr
-141-18-46-93-125941-12-37-2015
CFO To PAT
CFO To PAT%
-163.5-126.8232.2-110.4-98.4515.73,720.4-199.6-72.7-12.2204.6
CFO To EBITDA
CFO To EBITDA%
39.1113.177.633.8110.488.1121.935.571.942.292.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1230272231828326381366
Investing Cash Flow
Investing Cash FlowCr
-1097-21-86-3-12-43-29-50-59-37
Financing Cash Flow
Financing Cash FlowCr
82-39-1173-11-75-533543-25
Net Cash Flow
Net Cash FlowCr
-15-2-5917-4-130-8-35
Free Cash Flow
Free Cash FlowCr
-141-18-46-93-125941-12-37-2015
CFO To PAT
CFO To PAT%
-163.5-126.8232.2-110.4-98.4515.73,720.4-199.6-72.7-12.2204.6
CFO To EBITDA
CFO To EBITDA%
39.1113.177.633.8110.488.1121.935.571.942.292.9

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
234304287272105398595464463326245757
Price To Earnings
Price To Earnings
20.527.487.22.04.9
Price To Sales
Price To Sales
0.40.40.30.30.10.40.40.30.30.40.30.6
Price To Book
Price To Book
0.40.50.50.50.20.71.00.80.80.60.41.3
EV To EBITDA
EV To EBITDA
19.023.618.310.719.69.215.313.218.329.17.311.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
29.128.725.925.124.527.323.822.625.523.516.816.8
OPM
OPM%
5.33.84.15.92.88.65.04.63.52.07.37.9
NPM
NPM%
-1.3-3.41.4-1.8-3.11.50.2-0.8-3.5-7.13.312.4
ROCE
ROCE%
1.3-1.23.42.0-0.64.03.72.11.1-4.66.86.8
ROE
ROE%
-1.2-4.12.0-3.3-5.52.70.4-2.1-8.6-20.95.75.7
ROA
ROA%
-0.6-2.00.9-1.4-2.31.20.2-0.9-3.5-7.32.92.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
234304287272105398595464463326245757
Price To Earnings
Price To Earnings
20.527.487.22.04.9
Price To Sales
Price To Sales
0.40.40.30.30.10.40.40.30.30.40.30.6
Price To Book
Price To Book
0.40.50.50.50.20.71.00.80.80.60.41.3
EV To EBITDA
EV To EBITDA
19.023.618.310.719.69.215.313.218.329.17.311.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
29.128.725.925.124.527.323.822.625.523.516.816.8
OPM
OPM%
5.33.84.15.92.88.65.04.63.52.07.37.9
NPM
NPM%
-1.3-3.41.4-1.8-3.11.50.2-0.8-3.5-7.13.312.4
ROCE
ROCE%
1.3-1.23.42.0-0.64.03.72.11.1-4.66.86.8
ROE
ROE%
-1.2-4.12.0-3.3-5.52.70.4-2.1-8.6-20.95.75.7
ROA
ROA%
-0.6-2.00.9-1.4-2.31.20.2-0.9-3.5-7.32.92.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Kanoria Chemicals & Industries Ltd is fundamentally a chemical manufacturer - its Alco Chemicals Division makes the industrial intermediates that go into construction, paint, pharma and agrochemicals, and that division has been the group’s backbone since incorporation in 1960. Over the decades, the cash flows from chemicals were used to build two additional businesses on two other continents: an electronic automotive-components operation across Europe and North America, and an integrated denim-textile plant in Ethiopia. The recurring approach is to take a position in a foundational industrial input, deepen it with in-house technology until it earns market leadership, and then use the surplus to plant a flag in a structurally different geography or industry - a pattern that now shapes a group in the middle of a deliberate exit from both its non-chemical engines. # Business segments Three engines at different stages - a chemicals cash cow that supplies India’s construction and industrial growth, a European auto-electronics platform being sold, and an African denim unit being wound down - each built with the cash flows of the one before. ## 1. Alco Chemicals: the industrial-intermediates engine that funds everything else **KCIL is India’s sole indigenous producer of phenolic resins with plants on both coasts, and it runs the country’s largest formaldehyde capacity - a scale position in commodity chemicals where demand tracks India’s GDP and construction spending.** - **Market leadership in intermediates** - the division makes formaldehyde, pentaerythritol, hexamine, sodium formate, phenolic resins and acetaldehyde, and the company describes itself as a leading domestic producer in most of these products, with a significant presence in the rest. It is the only indigenous manufacturer of phenolic resin in India with a manufacturing presence on both the West and East coasts, so customers who need a local supply chain have no alternative. - **In-house technology as a cost moat** - the formaldehyde plants use the FORMOX process and metal-oxide-based technology, which give an operational cost advantage over older processes, while the technologies for pentaerythritol, hexamine and phenolic resins were developed in-house and continuously refined to compete globally on cost and quality. The R&D centre at Ankleshwar is recognised by India’s Department of Scientific and Industrial Research, and a dedicated new-product-development cell is working on triacetin and pentaerythritol derivatives. - **Global resin partnerships fill out the portfolio** - the phenolic resin plant has collaborative agreements with Hexion Inc., a global leader in thermoset resins, and ASK Chemicals, a global player in foundry solutions, to add specialised high-value products that KCIL would otherwise take years to develop alone. - **Protected by an anti-dumping wall** - cheaper imports of pentaerythritol had been a persistent threat, but anti-dumping duty was imposed in May 2024, creating a fairer competitive environment and supporting margins in a business where input costs and sales realisations move together because the products are commodities. ## 2. Electronic automotive components: a European luxury-electronics platform being sold **APAG designs and produces the electronic control units and lighting systems that sit behind the grille of a Porsche or a Cadillac - a single-source supplier to Europe’s premium car groups, now being divested.** - **Single-source supplier to luxury OEMs** - APAG is the sole supplier on its contracted programmes for the VW-Audi-Porsche group, the BMW-Mini-Rolls Royce group, Stellantis brands including Maserati and Alfa Romeo, GM’s Cadillac, and Ford, with additional business wins from Tesla and industrial names like Illinois Tool Works. The model works on platform-specific contracts, so once a car programme is awarded, the revenue is locked in for the life of that model. - **Propulsion-agnostic, with a foot in automation** - the portfolio of over 250 finished products includes ADAS subcomponents, which means the parts go into both fossil-fuel and electric vehicles, insulating the business from the pace of the EV transition. - **Czech-to-Canada production line** - semi-finished products are made at the consolidated European facility in the Czech Republic and then shipped to the Canadian plant for complex assembly and testing before delivery to North American customers, a setup that balances European engineering with proximity to the US market. - **Cost base shifting to India** - in response to OEM price pressure and customers insourcing programmes, APAG has moved back-office functions and strategic procurement to India at lower employee cost, while rationalising its European and North American R&D teams and growing the India-based engineering team. - **Exit in two tranches** - in July 2025 the board approved the sale of KCIL’s entire stake in APAG Holding AG: strategic investors infused capital for roughly 63% of the equity, diluting KCIL from 55% to about 14.3%, with the remaining stake to be transferred in a second tranche by FY 2029-30, and APAG ceased to be a subsidiary on 31 July 2025. ## 3. Textiles: an Ethiopian denim plant being wound down **Kanoria Africa Textiles runs an integrated denim factory in Ethiopia that was built to exploit duty-free access to the US and Europe, but chronic foreign-currency shortages and civil unrest have made it a disposal candidate.** - **Duty-free access to rich-world markets** - Ethiopia’s eligibility under the African Growth & Opportunity Act gives duty-free entry to the US, the Everything But Arms scheme does the same for the EU, and the AfCFTA treaty opens the entire African continent, which is why multinational apparel brands opened sourcing offices in the country. - **Integrated from cotton to garment** - the unit spins, weaves and finishes denim fabric, and a garmenting division was added around FY20-21 to capture more value by sewing the fabric into finished jeans, leveraging Ethiopia’s low labour costs. - **Strangled by forex and conflict** - an acute shortage of foreign currency in Ethiopia made it nearly impossible to import raw materials, and political crisis in the Amhara region disrupted supply chains, forcing the business to rely mainly on the domestic market. The Ethiopian Birr was then sharply devalued from 56 to 130 per US dollar under an IMF package, which slashed the dollar value of local revenue even as it opened a path back to exports. - **Stake being sold down** - in February 2025, KCIL entered an agreement to sell a 13.79% holding in KAT to Hyperlabs Pte. Ltd., Singapore, for USD 2 million, signalling a deliberate retreat from a geography that has proven too difficult to operate in. # Group structure and partners **KCIL is the listed Indian parent, controlled by the Kanoria family through Vardhan Limited, and it is in the process of exiting both its overseas subsidiaries to refocus on the domestic chemicals business.** - The holding company is Vardhan Limited, and key management includes R.V. Kanoria as Chairman & Managing Director and his son S.V. Kanoria as Wholetime Director. - The Alco Chemicals Division is operated directly by KCIL as a standalone Indian business with no intermediate holding company. - The electronic automotive components business was held through APAG Holding AG in Switzerland, with step-down operating subsidiaries in Switzerland, the Czech Republic, Germany, the US and Canada; after the July 2025 divestment, KCIL’s stake fell to roughly 14.3% and APAG ceased to be a subsidiary. - The textiles business is held through Kanoria Africa Textiles plc in Ethiopia, which became a wholly owned subsidiary in March 2021 and in which KCIL is now selling down its stake. - The chemicals division’s phenolic resin plant has collaborative agreements with Hexion Inc. and ASK Chemicals to add specialised high-value products to the manufacturing portfolio.

Documents — Kanoria Chemicals & Industries Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/oguzvaqogtb0dxgjptm4zrxx.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/ng4zneh8emexnhkw10labklo.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/cbu8e0tu64l74fufqo0k0be8.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/nrbbpp02xjtp1h9s0wx4rarv.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/padz7gdzaee9pxrfcue0a6l8.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/g98tffkequlmkilea979rnap.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/61qmv9i75apvwn1743nej8w5.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/46pri5lk16pp3ska0o3g3cwp.pdf
  • Q1 FY2025 Investor Presentation (Jun 2024, PDF): https://www.stockscans.in/document/vvl0mpd3ot0rey0pogbx4n86.pdf
  • Q1 FY2024 Investor Presentation (Jun 2023, PDF): https://www.stockscans.in/document/lqeo61yu5wy1wgapfh5xux6w.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/ptnxxkf58j1t74mgr2tcfjmc.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/44a318geloo86p479pjde4po.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/d6e1nobp0lannep98owziq60.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/u7sw5twu9x11payumwi11jw6.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/6j11auwmrgumajz5d47oq0u3.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/8r7qtbmw5k7duihxhzbj1zzi.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/bki4g2r7laob47q43aohq14q.pdf